Skip to the page

Data / Drug companies / Piperacillin and tazobactam

Piperacillin and tazobactam: 13 companies and 47 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Piperacillin and tazobactam is listed in the FDA National Drug Code Directory by 13 companies, with 47 products in commercial distribution. 47 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, for solution; injection, powder, lyophilized, for solution, and the newest product started marketing on September 8, 2025.

The request: Get every company that lists piperacillin and tazobactam in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
13
Products
47
Generic (ANDA) products
47 (100.0%)
Application numbers
10
Routes
Intravenous, Parenteral
openFDA record search
api.fda.gov

Companies that list piperacillin and tazobactam

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Fresenius Kabi USA, LLC7injection, powder, lyophilized, for solution; injection, powder, for solutionGeneric drugs (ANDA)March 20, 2023
Fresenius Kabi USA, LLC6injection, powder, lyophilized, for solutionGeneric drugs (ANDA)May 18, 2018
Sandoz Inc5injection, powder, lyophilized, for solutionGeneric drugs (ANDA)October 25, 2021
Apotex Corp.4injection, powder, for solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 26, 2023
Avenacy, LLC4injection, powder, for solutionGeneric drugs (ANDA)September 1, 2025
Hospira, Inc.4injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 14, 2016
Shandong Anxin Pharmaceutical Co., Ltd.4injection, powder, for solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 14, 2023
BluePoint Laboratories3injection, powder, for solutionGeneric drugs (ANDA)August 11, 2021
Onesource Specialty Pharma Limited3injection, powder, for solutionGeneric drugs (ANDA)June 30, 2016
Armas Pharmaceuticals Inc.2injection, powder, for solutionGeneric drugs (ANDA)April 14, 2022
Civica, Inc.2injection, powder, for solutionGeneric drugs (ANDA)September 8, 2025
Milla Pharmaceuticals Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 11, 2023
WG Critical Care, LLC1injection, powder, for solutionGeneric drugs (ANDA)October 20, 2009

Dosage forms

Dosage formProductsShare
Injection, powder, for solution2451.1%
Injection, powder, lyophilized, for solution2348.9%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)47100%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.